KRSA

36.9854.33%
KB

Kyle Breidenstine

Senior Vice President of Finance & Treasurer

Mr. Kyle Breidenstine, MBA, CPA, is Senior Vice President of Finance & Treasurer of Korsana Biosciences, Inc. from 2025. Mr. Breidenstine joined the Korsana Biosciences, Inc. in 2025. Mr. Breidenstine served as VP of Finance & Controller of PepGen Inc. from 2022 until 2025. He played a key role in PepGen’s initial public offering and he has led the finance team’s transition to a public company, including the build-out of the accounting, public company reporting and FP&A functions. Prior to PepGen, Kyle held roles of increasing responsibility with the finance group at Orchard Therapeutics, where he was a key partner in the Company’s IPO and multiple successful equity offerings. Kyle became a CPA in 2012 and worked in the PwC assurance practice, supporting public and private clients in the biotech and healthcare industries. He began his career in finance working as a budget analyst for the Commonwealth of Massachusetts. Kyle holds his MBA from the D’Amore-McKim School of Business at Northeastern University and his B.S. from Clark University.

Positions